Insider Trading activities at Biomarin Pharmaceutical Inc (BMRN) , Part 7

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc (BMRN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1048477.

Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.


28 insiders reported insider trading activities at Biomarin Pharmaceutical Inc (BMRN):
Insider trading activities of Slamon Dennis
Insider trading activities of Aselage Steve
Insider trading activities of Swiedler Stuart J
Insider trading activities of Cooper Jeffrey H
Insider trading activities of Heron Elaine J
Insider trading activities of Starr Christopher M
Insider trading activities of Spiegelman Daniel K
Insider trading activities of Bienaime Jean Jacques
Insider trading activities of Ajer Jeffrey Robert
Insider trading activities of Lewis Alan
Insider trading activities of Davis George Eric
Insider trading activities of Mueller Brian
Insider trading activities of Lapalme Pierre
Insider trading activities of Klein Joseph Iii
Insider trading activities of Hubbard Cristin
Insider trading activities of Guyer Charles Greg
Insider trading activities of Dere Willard H
Insider trading activities of Lawlis V Bryan
Insider trading activities of Sager Erich
Insider trading activities of Kakkis Emil D
Insider trading activities of Grey Michael G
Insider trading activities of Burkhart Erin
Insider trading activities of Fuchs Henry J
Insider trading activities of Alles Mark J
Insider trading activities of Meier Richard A
Insider trading activities of Baffi Robert
Insider trading activities of Wood Mark
Insider trading activities of Pyott David E I

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Biomarin Pharmaceutical Inc (BMRN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 11,732 $809,525 0 $0
2024 0 $0 255,921 $21,765,611 199,347 $12,744,795
2023 0 $0 291,124 $29,165,285 298,974 $20,261,651
2022 3,625 $314,468 311,275 $27,255,098 253,242 $11,640,873
2021 0 $0 191,799 $15,370,940 178,931 $4,916,104
2020 12,800 $1,005,145 360,561 $39,226,570 301,650 $13,887,132
2019 0 $0 186,014 $16,384,008 131,953 $2,232,548
2018 0 $0 443,177 $39,824,783 396,390 $13,170,758
2017 0 $0 308,037 $28,193,855 265,930 $7,893,265
2016 0 $0 1,279,525 $111,508,495 1,208,448 $28,339,513
2015 0 $0 411,289 $48,410,265 295,446 $6,663,831
2014 0 $0 340,526 $26,836,672 306,781 $7,721,726
2013 0 $0 742,342 $47,391,614 730,412 $15,099,577
2012 0 $0 1,247,954 $51,415,184 1,198,637 $17,833,395
2011 0 $0 332,106 $9,638,946 335,054 $4,369,131
2010 800 $16,062 564,962 $13,310,700 545,102 $7,510,310
2009 26,500 $306,434 74,572 $1,277,220 83,753 $455,350
2008 16,752 $218,171 1,172,420 $39,560,526 973,113 $8,505,589
2007 17,587 $107,335 576,356 $12,583,816 477,563 $3,277,058
2006 35,493 $362,571 184,500 $2,780,052 284,500 $1,766,260
2005 12,000 $103,551 81,142 $826,127 0 $0


Table 3. Detailed insider trading at Biomarin Pharmaceutical Inc (BMRN) , Part 7
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2012-12-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 9.86 29,580
2012-12-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 47.94 239,690
2012-12-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2012-11-29 Meier Richard A Sale 5,000 49.17 245,840
2012-11-29 Meier Richard A Option Ex 5,000 16.92 84,600
2012-11-28 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 5,916 48.31 285,819
2012-11-28 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 5,916 17.92 106,014
2012-11-23 Wood Mark (VP, Human Resources) Sale 2,665 48.92 130,366
2012-11-23 Wood Mark (VP, Human Resources) Option Ex 2,665 20.06 53,467
2012-11-19 Davis George Eric (SVP, General Counsel) Sale 7,363 48.50 357,105
2012-11-19 Davis George Eric (SVP, General Counsel) Option Ex 7,363 17.54 129,147
2012-11-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 48.05 384,368
2012-11-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,000 12.99 103,920
2012-11-15 Mueller Brian (VP, Corporate Controller) Sale 15,812 50.00 790,600
2012-11-15 Mueller Brian (VP, Corporate Controller) Option Ex 15,812 26.49 418,859
2012-11-15 Baffi Robert (EVP, Technical Operations) Sale 20,000 51.00 1,020,000
2012-11-15 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 17.54 350,800
2012-11-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 48.50 193,988
2012-11-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 12.99 51,960
2012-11-12 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 265 48.11 12,750
2012-11-12 Davis George Eric (SVP, General Counsel) Sale 11,575 48.67 563,308
2012-11-12 Davis George Eric (SVP, General Counsel) Option Ex 11,466 27.77 318,410
2012-11-12 Heron Elaine J Sale 1,875 48.33 90,626
2012-11-09 Davis George Eric (SVP, General Counsel) Sale 87,500 48.37 4,232,200
2012-11-09 Davis George Eric (SVP, General Counsel) Option Ex 87,500 16.42 1,436,750
2012-11-09 Heron Elaine J Sale 30,000 48.01 1,440,360
2012-11-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 48.42 96,844
2012-11-07 Heron Elaine J Sale 105,000 46.44 4,876,095
2012-11-07 Heron Elaine J Option Ex 105,000 18.54 1,946,700
2012-11-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 47.37 236,835
2012-11-07 Lewis Alan Sale 15,000 46.80 702,000
2012-11-07 Lewis Alan Option Ex 15,000 17.33 259,949
2012-11-05 Mueller Brian (VP, Corporate Controller) Sale 8,000 46.75 374,000
2012-11-05 Mueller Brian (VP, Corporate Controller) Option Ex 8,000 14.39 115,120
2012-11-05 Baffi Robert (EVP, Technical Operations) Sale 60,000 47.25 2,835,000
2012-11-05 Baffi Robert (EVP, Technical Operations) Option Ex 60,000 17.43 1,046,099
2012-11-05 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 46.00 460,000
2012-11-05 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2012-11-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 5,000 37.08 185,385
2012-11-01 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 5,000 11.05 55,250
2012-10-31 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 38.25 152,984
2012-10-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 9.86 29,580
2012-10-22 Wood Mark (VP, Human Resources) Sale 2,665 41.86 111,554
2012-10-22 Wood Mark (VP, Human Resources) Option Ex 2,665 20.06 53,467
2012-10-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 41.86 125,577
2012-10-22 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 9.86 29,580
2012-10-19 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 42.72 85,440
2012-10-16 Baffi Robert (EVP, Technical Operations) Sale 20,000 43.00 860,000
2012-10-16 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 17.33 346,599
2012-10-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 41.32 123,969
2012-10-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 9.86 29,580
2012-10-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 5,000 39.75 198,760
2012-10-01 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 5,000 11.05 55,250
2012-09-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 40.20 160,804
2012-09-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 9.86 39,440
2012-09-24 Wood Mark (VP, Human Resources) Sale 2,665 40.48 107,879
2012-09-24 Wood Mark (VP, Human Resources) Option Ex 2,665 20.06 53,467
2012-09-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 37.91 151,628
2012-09-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 9.86 39,440
2012-09-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 38.62 38,620
2012-09-04 Fuchs Henry J (EVP, Chief Medical Officer) Sale 5,000 37.76 188,790
2012-09-04 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 5,000 11.05 55,250
2012-08-22 Wood Mark (VP, Human Resources) Sale 2,665 37.95 101,139
2012-08-22 Wood Mark (VP, Human Resources) Option Ex 2,665 20.06 53,467
2012-08-06 Lewis Alan Sale 40,000 37.57 1,502,760
2012-08-06 Lewis Alan Option Ex 30,000 14.21 426,300
2012-08-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 5,000 38.63 193,145
2012-08-01 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 5,000 11.05 55,250
2012-07-23 Wood Mark (VP, Human Resources) Sale 2,666 39.25 104,632
2012-07-23 Wood Mark (VP, Human Resources) Option Ex 2,666 20.06 53,487
2012-07-10 Mueller Brian (VP, Corporate Controller) Sale 2,500 42.50 106,250
2012-07-10 Mueller Brian (VP, Corporate Controller) Option Ex 2,500 14.39 35,975
2012-07-02 Mueller Brian (VP, Corporate Controller) Sale 2,770 40.00 110,800
2012-07-02 Mueller Brian (VP, Corporate Controller) Option Ex 2,770 17.86 49,472
2012-07-02 Aselage Steve (EVP, Chief Business Officer) Sale 95,345 40.00 3,813,800
2012-07-02 Aselage Steve (EVP, Chief Business Officer) Option Ex 95,345 17.54 1,672,351
2012-07-02 Fuchs Henry J (EVP, Chief Medical Officer) Sale 15,000 40.28 604,215
2012-07-02 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 15,000 11.05 165,750
2012-06-27 Wood Mark (VP, Human Resources) Sale 812 38.00 30,856
2012-06-27 Wood Mark (VP, Human Resources) Option Ex 812 26.49 21,509
2012-06-22 Wood Mark (VP, Human Resources) Sale 1,853 36.83 68,244
2012-06-22 Wood Mark (VP, Human Resources) Option Ex 1,853 17.92 33,205
2012-06-06 Wood Mark (VP, Human Resources) Option Ex 1,250 .00 0
2012-06-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 5,000 35.02 175,080
2012-06-01 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 5,000 11.05 55,250
2012-05-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 6.46 64,600
2012-05-22 Mueller Brian (VP, Corporate Controller) Option Ex 150 .00 0
2012-05-22 Wood Mark (VP, Human Resources) Sale 2,666 38.01 101,331
2012-05-22 Wood Mark (VP, Human Resources) Option Ex 2,666 20.06 53,487
2012-05-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 38.50 577,515
2012-05-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 9.86 147,900
2012-05-15 Lawlis V Bryan Sale 8,900 38.51 342,765
2012-05-15 Lawlis V Bryan Option Ex 6,400 14.39 92,096
2012-05-15 Aselage Steve (EVP, Chief Business Officer) Sale 10,000 38.64 386,370
2012-05-15 Aselage Steve (EVP, Chief Business Officer) Option Ex 10,000 17.33 173,299
2012-05-15 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,741 38.64 67,279
2012-05-14 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 25,250 38.09 961,722
2012-05-14 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Ex 25,250 20.80 525,124
2012-05-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 38.13 571,890
2012-05-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 9.86 147,900
2012-05-12 Mueller Brian (VP, Corporate Controller) Option Ex 1,562 .00 0
2012-05-11 Wood Mark (VP, Human Resources) Sale 2,437 38.00 92,606
2012-05-11 Wood Mark (VP, Human Resources) Option Ex 2,437 26.49 64,556
2012-05-11 Davis George Eric (SVP, General Counsel) Sale 42,309 37.70 1,594,964
2012-05-11 Davis George Eric (SVP, General Counsel) Option Ex 40,000 14.39 575,600
2012-05-11 Aselage Steve (EVP, Chief Business Officer) Sale 26,160 37.68 985,630
2012-05-11 Aselage Steve (EVP, Chief Business Officer) Option Ex 21,530 15.96 343,726
2012-05-11 Bienaime Jean Jacques (Chief Executive Officer) Sale 25,500 38.07 970,861
2012-05-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 25,000 8.16 204,000
2012-05-08 Mueller Brian (VP, Corporate Controller) Sale 15,708 37.50 589,050
2012-05-08 Mueller Brian (VP, Corporate Controller) Option Ex 15,708 16.48 258,836
2012-05-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 36.52 547,800
2012-05-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 9.86 147,900
2012-05-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 35.96 179,800
2012-05-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 9.86 49,300
2012-05-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 36.00 360,000
2012-05-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 9.86 98,600
2012-05-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 36.68 366,800
2012-05-03 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 9.86 98,600
2012-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 35.72 357,200
2012-05-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 9.86 98,600
2012-05-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 20,000 35.00 699,920
2012-05-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 9.86 197,200
2012-05-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 5,000 34.99 174,950
2012-05-01 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 5,000 11.05 55,250
2012-04-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 22,000 34.84 766,568
2012-04-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 9.86 197,200
2012-04-23 Wood Mark (VP, Human Resources) Sale 1,853 34.54 64,006
2012-04-23 Wood Mark (VP, Human Resources) Option Ex 1,853 17.92 33,205
2012-04-20 Fuchs Henry J (EVP, Chief Medical Officer) Sale 7,691 35.00 269,185
2012-04-02 Fuchs Henry J (EVP, Chief Medical Officer) Sale 5,000 34.08 170,380
2012-04-02 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 5,000 11.05 55,250
2012-03-22 Wood Mark (VP, Human Resources) Sale 1,855 35.66 66,140
2012-03-22 Wood Mark (VP, Human Resources) Option Ex 1,855 17.92 33,241
2012-03-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 34.46 516,870
2012-03-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 6.47 97,050
2012-03-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 35.00 35,000
2012-02-29 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 36.26 36,258
2012-02-28 Lapalme Pierre Sale 20,000 36.01 720,100
2012-02-28 Lapalme Pierre Option Ex 20,000 8.47 169,400
2012-02-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 35.94 107,814
2012-02-24 Mueller Brian (VP, Corporate Controller) Sale 5,000 35.06 175,325
2012-02-24 Mueller Brian (VP, Corporate Controller) Option Ex 5,000 11.74 58,700
2012-02-24 Cooper Jeffrey H (SVP, Chief Financial Officer) Sale 83,036 35.07 2,911,989
2012-02-24 Cooper Jeffrey H (SVP, Chief Financial Officer) Option Ex 83,036 17.73 1,471,896
2012-02-24 Baffi Robert (EVP, Technical Operations) Sale 91,313 34.84 3,180,979
2012-02-24 Baffi Robert (EVP, Technical Operations) Option Ex 91,313 8.94 815,881
2012-02-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 35.20 70,396
2012-02-23 Grey Michael G Option Ex 30,000 16.92 507,600
2012-02-23 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 35.31 176,540

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.